sodium((2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxy-3-(stearoyloxy)propoxy)tetrahydro-2H-pyran-2-yl)methanesulfonate

ID: ALA3219625

Chembl Id: CHEMBL3219625

PubChem CID: 87348962

Max Phase: Preclinical

Molecular Formula: C27H51NaO11S

Molecular Weight: 584.77

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO[C@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O.[Na+]

Standard InChI:  InChI=1S/C27H52O11S.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(29)36-18-21(28)19-37-27-26(32)25(31)24(30)22(38-27)20-39(33,34)35;/h21-22,24-28,30-32H,2-20H2,1H3,(H,33,34,35);/q;+1/p-1/t21?,22-,24-,25+,26-,27+;/m1./s1

Standard InChI Key:  BHUSXKWWQIDZNB-QYOKHMATSA-M

Associated Targets(Human)

VEGFA Tclin Vascular endothelial growth factor A (159 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NUGC-3 (976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 584.77Molecular Weight (Monoisotopic): 584.3230AlogP: 2.86#Rotatable Bonds: 23
Polar Surface Area: 180.05Molecular Species: ACIDHBA: 10HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: -1.19CX Basic pKa: CX LogP: 3.91CX LogD: 1.53
Aromatic Rings: Heavy Atoms: 39QED Weighted: 0.07Np Likeness Score: 0.96

References

1. Takakusagi Y, Takakusagi K, Ida N, Takami M, Matsumoto Y, Kusayanagi T, Nakabayashi T, Aoki S, Murata H, Ohta K, Sugawara F, Sakaguchi K.  (2011)  Binding region and interaction properties of sulfoquinovosylacylglycerol (SQAG) with human vascular endothelial growth factor 165 revealed by biosensor-based assays,  (12): [10.1039/C1MD00180A]
2. Govindarajan M..  (2018)  Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.,  143  [PMID:29126728] [10.1016/j.ejmech.2017.10.015]

Source